Local Institution — Peoria, Arizona

Local Institution is a clinical research site located in Peoria, Arizona, United States.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution has participated in 5 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus, Rheumatoid Arthritis, Congestive Heart Failure.

Sponsors: Bristol-Myers Squibb, Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Peoria

Browse all research sites in Arizona · View every site in Peoria

• Research Site
• Arizona Center for Cancer Care-Peoria
• Pivotal Research Centers
• Sun Valley Arthritis Center Ltd
• Phoenix Medical Group
• GSK Investigational Site
• Pfizer Investigational Site
• Pivotal Research Center
• Novartis Investigative Site
• Trident Health Center
• Novo Nordisk Investigational Site
• Hope Research Institute

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution?

Local Institution has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution conducted?

Local Institution has 5 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Rheumatoid Arthritis, Congestive Heart Failure.

Is Local Institution accredited by Crixeo Clinical Trials?

Local Institution has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.